Here’s whether Eli Lilly & Co. (LLY) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+4.43% over 10 days); RSI 62 — healthy momentum range; strong 1-year return of +39.5%; 3-month momentum positive (+14.6%). Currently 4.2% off its 52-week high. Score: +7/7.
LLY is in a confirmed uptrend, trading above both its 50-day ($996.78) and 200-day ($958.45) moving averages. An RSI of 62.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +39.5% compares to +22.9% for SPY (beat the market by 16.7%).
$10,000 invested 1 year ago→ $13,953 today
vs. S&P 500 (SPY) — same period beat market by 16.7%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($958.45)
✓Above 50-day MA ($996.78)
✓RSI(14) neutral zone (30–70) — currently 62.4
✓Positive return (+39.5%)
✓Within 10% of period high (−4.2%)
Period Range $1,133.00
$623.78$1,182.73
RSI (14) 62.4
0 · OversoldOverbought · 100
Key Metrics
Price$1,133.00
Period Return+39.5%
Period High$1,182.73
Period Low$623.78
Drawdown−4.2%
MA-50$996.78
MA-200$958.45
RSI (14)62.4
Avg Volume (30d)3.3M
vs. SPYbeat by 16.7%
Return Rank#400 of 1246
Trend Signals
Price is above the 200-day moving average ($958.45)
Price is above the 50-day moving average ($996.78)